<dl id="ilis8"></dl><strike id="ilis8"><option id="ilis8"><em id="ilis8"></em></option></strike>
<cite id="ilis8"><option id="ilis8"></option></cite>
    1. <ul id="ilis8"></ul>
  1. <blockquote id="ilis8"><strong id="ilis8"></strong></blockquote>
    歡迎光臨:萊耀標(biāo)準(zhǔn)品網(wǎng)!
    ?您的位置:對(duì)照品 > 標(biāo)準(zhǔn)物質(zhì) > 計(jì)量院標(biāo)準(zhǔn)物質(zhì) >
    (&plusmn;)-ORG 28611
    產(chǎn)品基本信息
    產(chǎn)品編號(hào):O671020
    產(chǎn)品名稱:(&plusmn;)-ORG 28611
    產(chǎn)品CAS:784138-08-5
    規(guī)格含量:50mg
    產(chǎn)品價(jià)格:面議
    聯(lián)系我們:
    產(chǎn)品詳細(xì)介紹
    標(biāo)準(zhǔn)品編號(hào): O671020
    名稱: (±)-ORG 28611
    別名: 4-[[1-(Cyclohexylmethyl)-7-methoxy-1H-indol-3-yl]carbonyl]-1,2-dimethyl-piperazine; [1-(Cyclohexylmethyl)-7-methoxy-1H-indol-3-yl](3,4-dimethyl-1-piperazinyl)-methanone
    CAS號(hào): 784138-08-5
    分子式: C??H??N?O?
    分子量: 383.53
    類別: Standards; Pharmaceutical/API Drug Impurities/Metabolites;
    應(yīng)用: (±)-ORG 28611 is full agonist of the human cannabinoid (CB) receptors central CB1 (pEC50 = 7.6; pKi = 8.9) and peripheral CB2 (pKi = 8.8). ORG 28611 (0.1-1 μM/kg, intravenous) demonstrated antinociceptive activity in the mouse tail flick test and the mouse formalin paw test, and it was further evaluated clinically for use as a potential intravenous analgesic agent. Synthetic Cannabinoids
    參考文獻(xiàn)


    2011-2018 信陽(yáng)萊耀生物科技有限公司 版權(quán)所有

    中檢所標(biāo)準(zhǔn)品,對(duì)照品,標(biāo)準(zhǔn)氣體
    Keywords: 中檢所標(biāo)準(zhǔn)品 對(duì)照品 標(biāo)準(zhǔn)氣體
    <dl id="ilis8"></dl><strike id="ilis8"><option id="ilis8"><em id="ilis8"></em></option></strike>
    <cite id="ilis8"><option id="ilis8"></option></cite>
      1. <ul id="ilis8"></ul>
    1. <blockquote id="ilis8"><strong id="ilis8"></strong></blockquote>
      午夜三级做爰高潮 | 色婷婷亚洲色 | 草比综合网 | 加勒比无码综合 | 成人性生交片无码免费 |